Contact
searchSearch
HMP Global
Debra Patt
Interview
How Electronic Patient-Reported Outcomes Are Transforming Symptom Management and Value-Based Cancer Care
06/19/2026
Debra A. Patt, MD, PhD, MBA
In this interview, Deborah Patt, MD, PhD, MBA, discusses data presented at the 2026 American Society of Clinical Oncology Annual Meeting showing how electronic patient-reported outcomes and remote therapeutic monitoring can improve symptom...
In this interview, Deborah Patt, MD, PhD, MBA, discusses data presented at the 2026 American Society of Clinical Oncology Annual Meeting showing how electronic patient-reported outcomes and remote therapeutic monitoring can improve symptom...
In this interview, Deborah Patt,...
06/19/2026
First Report Managed Care
News
Pneumonia Hospitalizations Drive Rising Costs in Multiple Myeloma Care
06/08/2026
Grace Taylor, MS, MA
Pneumonia-related hospitalizations among patients with multiple myeloma are becoming increasingly costly despite declining mortality rates, highlighting persistent disparities and the urgent need for strategies to prevent serious infections...
Pneumonia-related hospitalizations among patients with multiple myeloma are becoming increasingly costly despite declining mortality rates, highlighting persistent disparities and the urgent need for strategies to prevent serious infections...
Pneumonia-related...
06/08/2026
First Report Managed Care
Jill Hellmann
Interview
Rethinking Cancer Attribution in Value-Based Oncology Care
06/03/2026
Jill Hellmann, MSN, RN
In this interview, a guest expert discusses research presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting on how the growing use of oral oncolytics and the increasing prevalence of concurrent cancers may expose...
In this interview, a guest expert discusses research presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting on how the growing use of oral oncolytics and the increasing prevalence of concurrent cancers may expose...
In this interview, a guest...
06/03/2026
First Report Managed Care
Conference Coverage
Digital Therapeutic Eases Fatigue and Mood Symptoms for Patients With Breast Cancer
06/04/2025
Grace Taylor, MS, MA
A smartphone-based digital therapeutic shows promise in reducing fatigue, pain, and mood symptoms in patients with breast cancer.
A smartphone-based digital therapeutic shows promise in reducing fatigue, pain, and mood symptoms in patients with breast cancer.
A smartphone-based digital...
06/04/2025
First Report Managed Care
Conference Coverage
Cytarabine-Based Regimens Linked to Longer Relapse-Free Survival in Mantle Cell Lymphoma
06/03/2025
Hannah Musick
Cytarabine-based induction therapy in mantle cell lymphoma was linked to longer relapse-free survival compared to non-cytarabine regimens, though overall survival differences were not statistically significant.
Cytarabine-based induction therapy in mantle cell lymphoma was linked to longer relapse-free survival compared to non-cytarabine regimens, though overall survival differences were not statistically significant.
Cytarabine-based induction...
06/03/2025
Journal of Clinical Pathways
Conference Coverage
Research Shows that Health Care Costs Vary Based on HIC Status in Patients With NSCLC
06/13/2023
Emry Lloyd
In an abstract presented at ASCO 2023, researchers compared real-world data on health care costs for HIC-H and HIC-C patients with NSCLC before and after they received the HIC test.
In an abstract presented at ASCO 2023, researchers compared real-world data on health care costs for HIC-H and HIC-C patients with NSCLC before and after they received the HIC test.
In an abstract presented at ASCO...
06/13/2023
Journal of Clinical Pathways
Conference Coverage
Improving Oncology Acute Care Event Prediction Through Machine Learning Algorithms
06/08/2023
Hannah Musick
Combining patient-reported outcome measures (PROMs) with electronic health record (EHR) data may improve machine learning algorithms’ ability to predict the risk of acute care events in patients with cancer.
Combining patient-reported outcome measures (PROMs) with electronic health record (EHR) data may improve machine learning algorithms’ ability to predict the risk of acute care events in patients with cancer.
Combining patient-reported...
06/08/2023
First Report Managed Care
Conference Coverage
Significant Number of Solid Tumor Drug Approvals Added Complexity to Existing Regimens
06/08/2023
Maria Asimopoulos
A significant portion of drug approvals for nonhematologic solid cancers in the last 12 years were for indications which added to existing regimens, which could increase costs and exposure to side effects, researchers said.
A significant portion of drug approvals for nonhematologic solid cancers in the last 12 years were for indications which added to existing regimens, which could increase costs and exposure to side effects, researchers said.
A significant portion of drug...
06/08/2023
First Report Managed Care
Conference Coverage
Medicaid Expansion Linked to Early Breast Cancer Treatment, Survival Among Young Adult Women
06/02/2023
Hannah Musick
A new study showed Medicaid expansion in the United States was associated with increased receipt of timely, guideline-concordant breast cancer treatment and improved survival for young adult women.
A new study showed Medicaid expansion in the United States was associated with increased receipt of timely, guideline-concordant breast cancer treatment and improved survival for young adult women.
A new study showed Medicaid...
06/02/2023
First Report Managed Care
Conference Coverage
Breast Cancer Data Discrepancies Found Across National Tumor Registries
06/02/2023
Hannah Musick
Researchers at the 2023 ASCO Annual Meeting compared data on breast cancer cases in 3 national databases to identify differences in case coverage.
Researchers at the 2023 ASCO Annual Meeting compared data on breast cancer cases in 3 national databases to identify differences in case coverage.
Researchers at the 2023 ASCO...
06/02/2023
First Report Managed Care
Conference Coverage
FDA Oncology Approvals Commonly Involve Surrogate Endpoints, Analysis Shows
06/02/2023
Maria Asimopoulos
In an updated analysis presented at the 2023 ASCO Annual Meeting, researchers examined the frequency with which surrogate endpoints were used to support oncology approvals from 2006 to 2022.
In an updated analysis presented at the 2023 ASCO Annual Meeting, researchers examined the frequency with which surrogate endpoints were used to support oncology approvals from 2006 to 2022.
In an updated analysis presented...
06/02/2023
First Report Managed Care
Conference Coverage
Medicare Telehealth Utilization Rates Lowest in Regions Lacking Access to Specialized Cancer Care
06/02/2023
Maria Asimopoulos
"Advocacy and policy efforts directed towards increasing access to telehealth can ensure equitable and timely access to specialized cancer care in these regions of need," researchers said.
"Advocacy and policy efforts directed towards increasing access to telehealth can ensure equitable and timely access to specialized cancer care in these regions of need," researchers said.
"Advocacy and policy efforts...
06/02/2023
First Report Managed Care
Conference Coverage
Peripheral Myeloid Cells as Effective Prognostic Markers in Patients With NSCLC Treated With Cemiplimab
06/01/2023
Grace Taylor, MS, MA
Researchers evaluated the use of myeloid cells, including monocytes and eosinophilis, as prognostic biomarkers for patients with non-small cell lung cancer (NSCLC) who have been treated with cemiplimab.
Researchers evaluated the use of myeloid cells, including monocytes and eosinophilis, as prognostic biomarkers for patients with non-small cell lung cancer (NSCLC) who have been treated with cemiplimab.
Researchers evaluated the use of...
06/01/2023
First Report Managed Care
Conference Coverage
Treating Advanced Melanoma With Fianlimab and Cemiplimab
06/01/2023
Grace Taylor, MS, MA
Researchers at ASCO 2023 presented data on the outcomes of treating patients with advanced melanoma, including patients who previously received adjuvant therapy, with fianlimab and cemiplimab.
Researchers at ASCO 2023 presented data on the outcomes of treating patients with advanced melanoma, including patients who previously received adjuvant therapy, with fianlimab and cemiplimab.
Researchers at ASCO 2023...
06/01/2023
First Report Managed Care

Global oncology professionals gather to discuss clinical advances in every area of cancer research, the current and future landscape of oncology care, and more.

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use